0141 352 98 55

25 Blythswood Square, Glasgow, G2 4BL

Pfizer and BioNTech gain approval on new COVID-19 vaccine
December 2, 2020

This long-awaited moment has finally arrived! This morning, Pfizer and BioNTech’s vaccine has been approved for use in the UK as early as next week. It is the fastest vaccine ever to be developed, taking only 10 months to convert the concept into reality, a process that ordinarily takes 10 years.2

BNT162b2, which offers 95% protection has been approved by Britain for largescale immunisation against COVID-19.2,3 MHRA (Medicines and Healthcare products Regulatory Agency) put out a statement saying that they “have carried out a rigorous scientific assessment of all the available evidence of quality, safety and effectiveness” and are pleased to announce the approval of this vaccine. They also suggested that “Vaccines are the most effective way to prevent infectious diseases” saving millions of lives worldwide every year.4

40 million doses have been ordered so far and the UK’s health secretary Matt Hancock has suggested that the first 800,000 doses will be available for vaccination from next week.2 He added that the doses will be administered as quickly as they can be made, but the bulk of the vaccination process will happen next year. Once the vaccine campaign is up and running with enough doses, it is thought over a million doses could be administered each week.

Though this is a fantastic step in the right direction, we cannot afford let our guard down. Experts have made it clear that we all must stay vigilant, respect social distancing and use face masks to beat the virus.

For more information on vaccination timings, who is likely to get vaccinated first and what the efficacy values of these covid-19 vaccines actually mean, check out last weeks blog post here.

References:

  1. Picture of confetti in the sky (https://unsplash.com/photos/uW_oj3jOPRg)
  2. https://www.bbc.co.uk/news/health-55145696
  3. https://www.gov.uk/government/news/uk-authorises-pfizer-biontech-covid-19-vaccine
  4. https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-vaccine-candidate-against

Recent Blogs

Appointment of Head of Data Quality

Appointment of Head of Data Quality

Data insights firm Talking Medicines, specialist in ‘social intelligence’ for the pharmaceutical industry, has appointed Donna Lawson to the position of Head of Data Quality. A particularly good fit for the role, Donna brings with her over two decades’ experience...

The effect of self-diagnosis on patient outcomes

The effect of self-diagnosis on patient outcomes

The internet is a wonderful place. You can find photos of places you want to visit, maps of your favourite mountain ranges, tutorials on how to bake the perfect birthday cake…the list goes on. In recent years, however, there has been a marked increase in the number of...

Pharma Business International Interview

Pharma Business International Interview

Pharma Business International spoke with Jo Halliday, CEO of Talking Medicines, the world’s first social intelligence company designed specifically for the pharmaceutical industry.  The full article can be found here on page 10-11 Tell us about Talking Medicines?...

Tracking Covid vaccine progress through Medsmart®

Tracking Covid vaccine progress through Medsmart®

In the race against new super spreading virus variants, the UK among other countries have implemented a fast streamed vaccine programme to protect the vulnerable as quickly as possible. Since the beginning of January, 17,916,181 people in the UK have been given their...